SLCTR_2015_023
Effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic Fatty Liver Disease (NAFLD)
A randomized controlled, double blinded, clinical trial investigating the effects of Vitamin E Delta-tocotrienol supplementation in Nonalcoholic fatty liver disease
Armed Forces Institute of Pathology, Pakistan·Phase 2·Sri Lanka Clinical Trials RegistryRecruiting
Study focus
- Disease/Condition
- Nonalcoholic fatty liver disease (NAFLD)
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Armed Forces Institute of Pathology, Pakistan
- Location
- Pakistan
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Liver disease, unspecifiedInflammatory liver disease, unspecifiedAlcoholic liver disease, unspecifiedAlcoholic fatty liverToxic liver disease, unspecified
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2015_023
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2015_023 through Pure Global AI's free database. This Phase 2 trial is sponsored by Armed Forces Institute of Pathology, Pakistan and is currently Recruiting. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.